Therefore, obesity may have an impact on the PD-L1/PD-1 pathway in the interaction between tumor cells and immune cells, and further exploration of its underlying mechanism will help reveal the therapeutic response mode and drug resistance mechanism of ICB. The gene discussed is CD274; the disease is obesity disorder.